Document is current
Any future updates will be listed below
-
Authors
Yamasaki, Satoshi
Yanada, Masamitsu
Araie, Hiroaki
Fukuda, Takahiro
Kanda, Yoshinobu
Tashiro, Haruko
Uchida, Naoyuki
Ozeki, Kazutaka
Ota, Shuichi
Onishi, Yasushi
Doki, Noriko
Oyake, Tatsuo
Takada, Satoru
Sakurai, Masatoshi
Kondo, Yukio
Nakamae, Hirohisa
Kawakita, Toshiro
Onizuka, Makoto
Atsuta, Yoshiko
Konuma, Takaaki
- License Information
-
More Information
Article History
Received: 23 December 2024
Accepted: 21 March 2025
First Online: 31 March 2025
Declarations
:
: The study was approved by the Data Management Committee of the Japanese Society for Hematopoietic Cell Transplantation and the Institutional Review Board of St. Mary’s Hospital.
: The Transplant Registry Unified Management Program database contains physician-reviewed data. Observational studies based on the Transplant Registry Unified Management Program database are performed with informed consent.
: MS owns stock in Celaid Therapeutics but declares no potential competing interests. SY, MY, HA, TF, Y Kanda, HT, NU, KO, SO, YO, ND, TO, ST, Y Kondo, HN, T Kawakita, MO, YA, and T Konuma declare no potential competing interests.
